Rocket Lab Will Report Q3 Earnings Next Week on November 9. Ahead of It, Who Owns RKLB Stock?
Rocket Lab (RKLB) reports Q3 2026 earnings on November 9, with analysts expecting a $0.07 loss per share on $257.2M revenue. Traders anticipate a 15.17% stock move post-results. Major shareholders include Vanguard (9.14%) and Vanguard Index Funds (8.10%). Analysts from Cantor Fitzgerald and Citizens offer mixed price targets, with a consensus Strong Buy rating and $97.67 average target.
How this was made
The 30-second read
Why it matters
The main tradable element is the earnings timing and the market’s expectation for volatility around the print, which can drive hedging, straddle pricing, and pre-earnings positioning.
Market read
This is primarily an earnings setup that can affect near-term options pricing and risk management for RKLB into the Nov. 9 release.
What to watch
The article emphasizes ownership and analyst price targets, but traders may focus more on Neutron schedule risk and Electron demand commentary in the actual earnings release than on prior mission progress.
Background
The piece frames Rocket Lab’s upcoming Q3 2026 earnings date (Nov. 9) and summarizes consensus expectations, implied options move, and ownership structure.
Ticker impact
Rocket Lab is the subject, with Q3 results scheduled for Nov. 9 and consensus EPS/revenue plus an implied post-earnings move from options.
Likely elevated two-sided volatility into the earnings release as traders hedge around the expected EPS/revenue and the options-implied move.
The article provides consensus estimates and an options-based expected move magnitude, but it does not introduce new fundamentals beyond the upcoming earnings setup.
Market effects
Could influence sentiment toward space/launch providers and the broader commercial space supply chain around earnings season.
Limited, primarily US small/mid-cap growth and aerospace investor sentiment.
Low, as the catalyst is company-specific earnings rather than a global policy or supply shock.
Counterpoint
The options-implied move can be overstated if actual results and guidance land near expectations, leading to post-earnings volatility compression rather than directional follow-through.
Key entities
- companyRocket Lab
Subject of the article, scheduled to report Q3 2026 results on Nov. 9.
- analyst_firmCantor Fitzgerald
Reiterated Overweight and cited Neutron progress and Electron mission success.
- analyst_firmCitizens
Reiterated Market Outperform but lowered its price target citing Neutron launch delay.
